HRS-9190 vs Rocuronium for Muscle Relaxation During Anesthesia
Official title: A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Bolus-Administered HRS-9190 Versus Rocuronium for Tracheal Intubation and Maintaining Neuromuscular Blockade During General Anesthesia in Adults Undergoing Elective Surgery
Run by Jiangsu HengRui Medicine Co., Ltd. · NCT07746726 · Data updated 2026-11-12
This Phase 3 trial tests whether HRS-9190 can provide effective muscle relaxation for intubation and surgery as compared with rocuronium in adults undergoing elective general anesthesia.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. Industry-sponsored |
| Locations | 2 sites (Changsha, Hunan and 1 other locations) |
| Status | Recruiting |
| Started | September 2, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07746726 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing elective general anesthesia who can provide informed consent and meet the study’s eligibility criteria.
✕Probably not a fit
Patients with significant comorbidities affecting neuromuscular function or those who do not respond to study drugs may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults scheduled for elective surgery under general anesthesia are randomized to receive either HRS-9190 or rocuronium to produce neuromuscular blockade. The study measures how well each drug facilitates tracheal intubation, how quickly it works, how long its effects last, and recovery patterns. Safety is monitored through adverse events, vital signs, lab tests, and other safety indicators. Primary goal is to determine if HRS-9190 provides comparable or superior blockade for intubation with an acceptable safety profile. Secondary goals include onset time, duration of action, maintenance time during surgery, and recovery trajectory.
Why it matters
Potential benefit: If successful, HRS-9190 could offer a safe and effective alternative to rocuronium for muscle relaxation during anesthesia.
How similar studies have gone: Previous research in similar neuromuscular blockers has demonstrated proof of concept; the success of HRS-9190 in this specific comparison remains to be established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Able and willing to provide a written informed consent 2. Subjects requiring elective general anesthesia surgery 3. Meet specified age and body mass index (BMI) criteria 4. Conform to the ASA Physical Status Classification 5. Use of highly effective contraception for a specified period if applicable Exclusion Criteria: 1. History of significant neuromuscular, cardiovascular, respiratory, or neurological disorders 2. History of conditions affecting drug metabolism or anesthesia risk 3. Abnormal laboratory values indicating significant clinical abnormalities 4. Positive serology for specified infectious diseases 5. Known hypersensitivity to related medications 6. Recent use of medications interfering with neuromuscular function 7. History of mental illness, cognitive impairment, or epilepsy 8. Participation in another clinical trial within a specified period 9. Any other condition deemed unsuitable by the investigator
Where it's running
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting -
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China Recruiting
Study contacts
- Study coordinator: Lei Tang
- Email: lei.tang.lt31@hengrui.com
- Phone: +0518-81220121
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NMTCuff vs standard TOF monitoring during gynecologic oncology surgery
This study tests whether NMTCuff monitoring can better detect neuromuscular recovery than standard TOF monitoring in women undergoing laparoscopic gynecologic cancer surgery.
-
Two EMG Monitors for Deep NMB During Robotic/Thoracic Surgery
This study tests whether two quantitative EMG monitors (TetraGraph and TwitchView) can better maintain deep neuromuscular blockade during abdominal and thoracic surgery by comparing diaphragmatic movements and breath-initiation events in the same patient.
-
Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Monitoring
This study tests whether keeping a low, controlled amount of rocuronium during spine surgery helps nerve monitoring while improving the surgical field compared to stopping rocuronium after induction.
-
Safer muscle relaxant and reversal choice during anesthesia for people with chronic kidney disease
This trial will try to see if using cisatracurium with neostigmine leads to fewer breathing problems after surgery than using rocuronium with sugammadex in adults who have chronic kidney disease.
-
Comparing muscle responses for monitoring neuromuscular function after surgery
This study is testing a device to see if it can better monitor muscle function after surgery for patients who have received a specific muscle relaxant.
-
Investigating neuromuscular blockade effects on pain after laparoscopic surgery in children
This study tests if using different amounts of a muscle relaxant during laparoscopic surgery can help reduce pain in children aged 2 months to under 7 years after their operation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.